Nucleoside analogues with a 1,3-diene-Fe(CO)3 substructure: Stereoselective synthesis, configurational assignment, and apoptosis-inducing activity

Chemistry - A European Journal

Volumn 19, Issue 39, 2013, Pages 13017-13029

  Hirschhäuser, Christoph ^a   Velcicky, Juraj ^a   Schlawe, Daniel ^a   Hessler, Erik ^a   Majdalani, André ^a   Neudörfl, Jörg Martin ^a   Prokop, Aram ^b   Wieder, Thomas ^c   Schmalz, Hans Günther ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

antitumor agents; apoptosis; carbonyl ligands; iron; nucleosides

Indexed keywords

ANTI-TUMOR AGENTS; APOPTOSIS-INDUCING ACTIVITY; CARBONYL LIGAND; INTRAMOLECULAR PAUSON-KHAND REACTION; NUCLEOSIDES; STEREOSELECTIVE SYNTHESIS; STRUCTURE ACTIVITY RELATIONSHIPS; X RAY STRUCTURAL ANALYSIS;

BIOMOLECULES; CELL CULTURE; CELL DEATH; CIRCULAR DICHROISM SPECTROSCOPY; DRUG PRODUCTS; IODINE; IRON; STEREOCHEMISTRY; STEREOSELECTIVITY;

IRON COMPOUNDS;

EID: 84884531064     PISSN: 09476539     EISSN: 15213765     Source Type: Journal    
DOI: 10.1002/chem.201301672     Document Type: Article

References (69)

1. C. G. Hartinger, P. J. Dyson, Chem. Soc. Rev. 2009, 38, 391-401; For recent reviews, see
2. E. A. Hillard, G. Jaouen, Organometallics 2011, 30, 20-27
3. R. H. Fish, Aust. J. Chem. 2010, 63, 1505-1513
4. M. Patra, G. Gasser, ChemBioChem 2012, 13, 1232-1252
5. R. H. Fish, G. Jaouen, Organometallics 2003, 22, 2166-2177
6. W. Beck, K. Severin, Chem. Unserer Zeit 2002, 36, 356-365
7. N. Chavain, C. Biot, Curr. Med. Chem. 2010, 17, 2729-2745
8. E. Meggers, Chem. Commun. 2009, 1001-1010
9. G. Gasser, N. Metzler-Nolte, Curr. Opin. Chem. Biol. 2012, 16, 84-91.
10. E. Hillard, A. Vessieres, L. Thouin, G. Jaouen, C. Amatore, Angew. Chem. 2006, 118, 291-296
11. Angew. Chem. Int. Ed. 2006, 45, 285-290.
12. C. Biot, D. Taramelli, I. Forfar-Bares, L. A. Maciejewski, M. Boyce, G. Nowogrocki, J. S. Brocard, N. Basilico, P. Olliaro, T. J. Egan, Mol. Pharmaceutics 2005, 2, 185-193.
13. I. Ott, B. Kircher, R. Dembinski, R. Gust, Expert Opin. Ther. Patents 2008, 18, 327-337; for ferrocene-based compounds, see
14. D. R. vanStaveren, N. Metzler-Nolte, Chem. Rev. 2004, 104, 5931-5985; for compounds with anticancer activity, see
15. I. Ott, R. Gust, Arch. Pharm. 2007, 340, 117-126
16. G. Gasser, I. Ott, N. Metzler-Nolte, J. Med. Chem. 2011, 54, 3-25
17. J. Mattsson, P. Govindaswamy, A. K. Renfrew, P. J. Dyson, P. Stepnicka, G. Suess-Fink, B. Therrien, Organometallics 2009, 28, 4350-4357
18. G. S. Smith, B. Therrien, Dalton Trans. 2011, 40, 10793-10800; for CO-releasing molecules, see
19. T. Santos-Silva, A. Mukhopadhyay, J. D. Seixas, G. J. L. Bernardes, C. C. Romao, M. J. Romao, Curr. Med. Chem. 2011, 18, 3361-3366
20. W. Huber, R. Linder, J. Niesel, U. Schatzschneider, B. Spingler, P. C. Kunz, Eur. J. Inorg. Chem. 2012, 3140-3146
21. S. Romanski, B. Kraus, U. Schatzschneider, J.-M. Neudörfl, S. Amslinger, H.-G. Schmalz, Angew. Chem. 2011, 123, 2440-2444
22. Angew. Chem. Int. Ed. 2011, 50, 2392-2396.
23. D. Schlawe, A. Majdalani, J. Velcicky, E. Hessler, T. Wieder, A. Prokop, H.-G. Schmalz, Angew. Chem. 2004, 116, 1763-1766
24. Angew. Chem. Int. Ed. 2004, 43, 1731-1734.
25. J. C. Franke, M. Plotz, A. Prokop, C. C. Geilen, H.-G. Schmalz, J. Eberle, Biochem. Pharmacol. 2010, 79, 575-586.
26. A. Prokop, M. Eissmann, P. Jesse, G. Henze, P. James, J. Neudörfl, H. G. Schmalz, H. Lode, Blood 2006, 108, 179B
27. P. James, J. Neudörfl, M. Eissmann, P. Jesse, A. Prokop, H.-G. Schmalz, Org. Lett. 2006, 8, 2763-2766.
28. T. L. Su, B. Bennua, H. Vorbrüggen, H. J. Lindner, Chem. Ber. 1981, 114, 1269-1278
29. H. Vorbrüggen, B. Bennua, Chem. Ber. 1981, 114, 1279-1286
30. H. Vorbrüggen, G. Höfle, Chem. Ber. 1981, 114, 1256-1268
31. H. Vorbrüggen, K. Krolikiewicz, B. Bennua, Chem. Ber. 1981, 114, 1234-1255.
32. N. Rehnberg, G. Magnusson, J. Org. Chem. 1990, 55, 5467-5476.
33. H.-G. Schmalz, E. Hessler, J. W. Bats, G. Dürner, Tetrahedron Lett. 1994, 35, 4543-4546.
34. D. R. Brittelli, J. Org. Chem. 1981, 46, 2514-2520.
35. For a review on selective πcomplexation, see:, R. S. Paley, Chem. Rev. 2002, 102, 1493-1524.
36. E. Hessler, H.-G. Schmalz, G. Dürner, Tetrahedron Lett. 1994, 35, 4547-4550.
37. A. Pfletschinger, H.-G. Schmalz, W. Koch, Eur. J. Inorg. Chem. 1999, 1869-1880.
38. R. L. Schilsky, Oncology 2000, 14, 1297-1306.
39. F. Djedaini, D. Gree, J. Martelli, R. Gree, L. Leroy, J. Bolard, L. Toupet, Tetrahedron Lett. 1989, 30, 3781-3784.
40. C. Desgranges, G. Razaka, M. Rabaud, H. Bricaud, J. Balzarini, E. Declercq, Biochem. Pharmacol. 1983, 32, 3583-3590; for the decrease in toxicity, see
41. R. C. Cookson, P. J. Dudfield, R. F. Newton, P. Ravenscroft, D. I. C. Scopes, J. M. Cameron, Eur. J. Med. Chem. 1985, 20, 375-377
42. M. Ferrero, V. Gotor, Chem. Rev. 2000, 100, 4319-4348
43. O. Arjona, A. M. Gómez, J. C. López, J. Plumet, Chem. Rev. 2007, 107, 1919-2036.
44. J. Velcicky, A. Lanver, J. Lex, A. Prokop, T. Wieder, H.-G. Schmalz, Chem. Eur. J. 2004, 10, 5087-5110.
45. I. U. Khand, G. R. Knox, P. L. Pauson, W. E. Watts, J. Chem. Soc. D. 1971, 36; selected reviews
46. C. Aubert, L. Fensterbank, P. Garcia, M. Malacria, A. Simonneau, Chem. Rev. 2011, 111, 1954-1993
47. H.-W. Lee, F.-Y. Kwong, Eur. J. Org. Chem. 2010, 789-811
48. J. Blanco-Urgoiti, L. Anorbe, L. Perez-Serrano, G. Dominguez, J. Perez-Castells, Chem. Soc. Rev. 2004, 33, 32-42
49. K. M. Brummond, J. L. Kent, Tetrahedron 2000, 56, 3263-3283
50. Y. K. Chung, Coord. Chem. Rev. 1999, 188, 297-341
51. O. Geis, H.-G. Schmalz, Angew. Chem. 1998, 110, 955-958
52. Angew. Chem. Int. Ed. 1998, 37, 911-914; selected reviews on catalytic PKRs
53. J. H. Park, K.-M. Chang, Y. K. Chung, Coord. Chem. Rev. 2009, 253, 2461-2480
54. Y. Lan, L. Deng, J. Liu, C. Wang, O. Wiest, Z. Yang, Y.-D. Wu, J. Org. Chem. 2009, 74, 5049-5058.
55. H.-G. Schmalz, H. Jope, Tetrahedron 1998, 54, 3457-3464
56. M. Kurosu, Y. Kishi, J. Org. Chem. 1998, 63, 6100-6101
57. C. Chen, M. E. Layton, S. M. Sheehan, M. D. Shair, J. Am. Chem. Soc. 2000, 122, 7424-7425
58. G. Bringmann, J. Hinrichs, J. Kraus, A. Wuzik, T. Schulz, J. Org. Chem. 2000, 65, 2517-2527
59. P. Dorizon, C. Martin, J.-C. Daran, J.-C. Fiaud, H. B. Kagan, Tetrahedron: Asymmetry 2001, 12, 2625-2630
60. A. D. Lebsack, L. E. Overman, R. J. Valentekovich, J. Am. Chem. Soc. 2001, 123, 4851-4852
61. G. Delogu, D. Fabbri, C. deCandia, A. Patti, S. Pedotti, Tetrahedron: Asymmetry 2002, 13, 891-898.
62. J.-L. Luche, L. Rodriguez-Hahn, P. Crabbe, J. Chem. Soc. Chem. Commun. 1978, 601-602
63. A. S. Lee, A. W. Norman, W. H. Okamura, J. Org. Chem. 1992, 57, 3846-3854.
64. K. Y. Lee, Y. S. Choi, E. Gullen, S. Schlueter-Wirtz, R. F. Schinazi, Y. C. Cheng, C. K. Chu, J. Med. Chem. 1999, 42, 1320-1328
65. A. Holy, Coll. Czech. Chem. Commun. 1993, 58, 649-674.
66. T. Wieder, C. E. Orfanos, C. C. Geilen, J. Biol. Chem. 1998, 273, 11025-11031; see also
67. T. Decker, M.-L. Lohmann-Matthes, J. Immunol. Methods 1988, 115, 61-69.
68. M. Wilchek, E. A. Bayer, Methods Enzymol. 1990, 184, 5-13
69. M. Wilchek, E. A. Bayer, Methods Enzymol. 1990, 184, 14-45.